What are the treatment options for a patient diagnosed with Carcinoma (CA) of the tongue?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Tongue Carcinoma

For patients diagnosed with carcinoma of the tongue, treatment should be determined based on tumor stage, location, and patient factors, with surgery being the preferred primary treatment for oral tongue cancers and chemoradiotherapy often recommended for advanced or base of tongue tumors. 1

Initial Assessment and Staging

Before determining treatment, comprehensive evaluation is essential:

  • Mandatory biopsy for pathological confirmation
  • Complete head and neck examination
  • Contrast-enhanced CT and/or MRI for assessment of primary tumor and neck
  • Chest imaging to rule out metastases or second primaries
  • PET-CT recommended for stage III-IV disease 1
  • Dental/prosthodontic evaluation with jaw imaging 1

Treatment Options by Location and Stage

Oral Tongue Carcinoma

  • Early Stage (T1-T2):

    • Surgery is the preferred primary treatment option 1
    • Conservative approaches including transoral techniques
    • Partial glossectomy with appropriate margins
    • Selective neck dissection may be indicated even for clinically negative neck
  • Advanced Stage (T3-T4):

    • Surgery followed by adjuvant therapy
    • Postoperative radiotherapy (58-63 Gy) for high-risk features 1
    • Postoperative chemoradiotherapy (66 Gy with cisplatin) for positive margins and extranodal extension 1
    • Microvascular reconstruction techniques to improve functional outcomes 1

Base of Tongue Carcinoma

  • Early Stage:

    • Either surgery or primary radiotherapy
    • Higher likelihood of regional metastasis compared to oral tongue tumors 2
  • Advanced Stage:

    • Concurrent chemoradiotherapy is often preferred for organ preservation 3, 1
    • High-dose cisplatin (100 mg/m² on days 1,22, and 43) is preferred when using systemic therapy/RT 3
    • Total laryngectomy may be indicated for extensive disease with laryngeal involvement 3
    • Induction chemotherapy with management based on response is an option 3

Surgical Considerations

  • Comprehensive neck dissection for the side with clinically positive nodes (levels I-V) 1
  • Selective neck dissection (levels I-IV) for the contralateral side when indicated 1
  • Bilateral neck dissection is mandatory for tumors crossing the midline 1
  • For extensive tumors with poor pretreatment function, more extensive surgery rather than organ-preservation approaches may achieve better outcomes 1

Radiation and Systemic Therapy Options

  • Intensity-modulated radiation therapy (IMRT) is preferred to minimize xerostomia 1
  • For patients requiring systemic therapy:
    • Pembrolizumab monotherapy for PD-L1 positive patients with no prior platinum therapy 1
    • Pembrolizumab plus platinum/5-FU for PD-L1 negative patients 1
    • Nivolumab or pembrolizumab for patients with prior platinum therapy 1

Prognostic Factors and Survival

  • TNM stage is the most important prognostic factor 4
  • 5-year survival rates vary significantly by location and stage:
    • Oral tongue cancer: approximately 43% overall survival
    • Base of tongue cancer: approximately 27% overall survival 2
    • Stage I tumors: over 80% disease-specific survival 2
  • Patients with base of tongue tumors typically present with more advanced disease and poorly differentiated lesions, resulting in poorer prognosis 2

Post-Treatment Follow-up

  • Regular clinical examinations to monitor for recurrence and second primaries
  • Most recurrences occur within the first 2 years after treatment 1
  • Imaging studies as clinically indicated
  • Assessment of treatment-related complications and functional outcomes
  • Thyroid function monitoring with TSH every 6-12 months after neck irradiation 1
  • Nutritional assessment and support as needed 1

Important Clinical Considerations

  • Base of tongue tumors often present with advanced disease due to fewer early symptoms compared to oral tongue tumors 2
  • Accurate imaging assessment of depth of invasion is crucial for staging, with intraoral ultrasonography being most accurate for early-stage tumors 5
  • Patient factors such as age, alcohol consumption, and p53 expression may influence prognosis within specific stages 4

References

Guideline

Head and Neck Cancer Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Carcinoma of the tongue: a case series analysis of clinical presentation, risk factors, staging, and outcome.

Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2004

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.